State Street’s Vertex Pharmaceuticals VRTX Stock Holding History

State Street’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.24B	Buy	11,730,139 +40,600	+0.3%	+$18.9M	0.18%	99
2025 Q4	$5.3B	Buy	11,689,539 +83,539	+0.7%	+$36M	0.18%	99
2025 Q3	$4.55B	Sell	11,606,000 -169,227	-1%	-$70.7M	0.16%	110
2025 Q2	$5.24B	Sell	11,775,227 -13,430	-0.1%	-$6.19M	0.2%	101
2025 Q1	$5.72B	Sell	11,788,657 -190,748	-2%	-$88.9M	0.24%	82
2024 Q4	$4.82B	Buy	11,979,405 +163,156	+1%	+$75.6M	0.19%	95
2024 Q3	$5.5B	Buy	11,816,249 +90,173	+0.8%	+$43.3M	0.22%	79
2024 Q2	$5.5B	Sell	11,726,076 -280,407	-2%	-$122M	0.24%	74
2024 Q1	$5.02B	Sell	12,006,483 -77,335	-0.6%	-$32.7M	0.22%	84
2023 Q4	$4.92B	Buy	12,083,818 +44,272	+0.4%	+$16.4M	0.24%	77
2023 Q3	$4.19B	Sell	12,039,546 -292,047	-2%	-$102M	0.23%	83
2023 Q2	$4.34B	Buy	12,331,593 +124,141	+1%	+$41.8M	0.23%	84
2023 Q1	$3.85B	Sell	12,207,452 -162,978	-1%	-$48.9M	0.22%	95
2022 Q4	$3.57B	Buy	12,370,430 +75,639	+0.6%	+$23.1M	0.21%	98
2022 Q3	$3.56B	Buy	12,294,791 +30,742	+0.3%	+$8.85M	0.23%	88
2022 Q2	$3.46B	Buy	12,264,049 +211,286	+2%	+$56.6M	0.21%	94
2022 Q1	$3.15B	Sell	12,052,763 -304,152	-2%	-$72.2M	0.16%	127
2021 Q4	$2.71B	Buy	12,356,915 +33,499	+0.3%	+$6.51M	0.13%	143
2021 Q3	$2.24B	Buy	12,323,416 +617,593	+5%	+$121M	0.12%	156
2021 Q2	$2.36B	Buy	11,705,823 +530,785	+5%	+$111M	0.12%	155
2021 Q1	$2.4B	Sell	11,175,038 -261,026	-2%	-$57.3M	0.14%	137
2020 Q4	$2.7B	Buy	11,436,064 +74,118	+0.7%	+$17M	0.17%	115
2020 Q3	$3.09B	Sell	11,361,946 -306,299	-3%	-$84.5M	0.21%	90
2020 Q2	$3.39B	Buy	11,668,245 +219,002	+2%	+$59.4M	0.25%	82
2020 Q1	$2.72B	Buy	11,449,243 +54,718	+0.5%	+$12.6M	0.24%	87
2019 Q4	$2.49B	Buy	11,394,525 +80,917	+0.7%	+$16.4M	0.17%	119
2019 Q3	$1.92B	Sell	11,313,608 -60,634	-0.5%	-$10.7M	0.14%	158
2019 Q2	$2.09B	Sell	11,374,242 -109,804	-1%	-$19.2M	0.16%	133
2019 Q1	$2.11B	Buy	11,484,046 +643,769	+6%	+$119M	0.16%	120
2018 Q4	$1.8B	Sell	10,840,277 -53,978	-0.5%	-$9.35M	0.16%	128
2018 Q3	$2.1B	Buy	10,894,255 +404,711	+4%	+$72.1M	0.16%	126
2018 Q2	$1.78B	Buy	10,489,544 +455,166	+5%	+$70.6M	0.15%	137
2018 Q1	$1.64B	Sell	10,034,378 -941,685	-9%	-$154M	0.14%	147
2017 Q4	$1.64B	Sell	10,976,063 -242,464	-2%	-$35.9M	0.13%	155
2017 Q3	$1.71B	Sell	11,218,527 -140,623	-1%	-$21.2M	0.15%	145
2017 Q2	$1.46B	Sell	11,359,150 -654,028	-5%	-$78.7M	0.13%	168
2017 Q1	$1.31B	Buy	12,013,178 +239,017	+2%	+$21M	0.12%	184
2016 Q4	$867M	Buy	11,774,161 +308,574	+3%	+$25.1M	0.08%	259
2016 Q3	$1,000M	Buy	11,465,587 +1,639,879	+17%	+$155M	0.1%	223
2016 Q2	$845M	Buy	9,825,708 +35,700	+0.4%	+$3.08M	0.09%	244
2016 Q1	$778M	Sell	9,790,008 -11,572	-0.1%	-$1.05M	0.08%	251
2015 Q4	$1.23B	Buy	9,801,580 +130,364	+1%	+$15.7M	0.13%	156
2015 Q3	$1.01B	Buy	9,671,216 +20,073	+0.2%	+$2.58M	0.12%	187
2015 Q2	$1.19B	Sell	9,651,143 -301,592	-3%	-$38M	0.13%	171
2015 Q1	$1.17B	Sell	9,952,735 -303,130	-3%	-$36.3M	0.12%	183
2014 Q4	$1.22B	Buy	10,255,865 +502,104	+5%	+$56.6M	0.12%	186
2014 Q3	$1.1B	Sell	9,753,761 -208,163	-2%	-$19.8M	0.12%	186
2014 Q2	$943M	Sell	9,961,924 -132,443	-1%	-$9.29M	0.1%	205
2014 Q1	$714M	Buy	10,094,367 +457,444	+5%	+$36.2M	0.08%	248
2013 Q4	$716M	Buy	9,636,923 +365,348	+4%	+$25.4M	0.08%	247
2013 Q3	$703M	Buy	9,271,575 +2,192,814	+31%	+$174M	0.09%	233
2013 Q2	$565M	Buy	+7,078,761	New	+$521M	0.07%	279